On June 12, 2012, in Washington, D.C., the Personalized Medicine Coalition, the American Association for Cancer Research and Feinstein Kean Healthcare convened “Turning the Tide Against Cancer Through Sustained Medical Innovation,” a national conference to consider the status and future of cancer innovation and personalized medicine. While recent scientific advances have generated both excitement and challenges in preventing, detecting, diagnosing and treating cancer, there is increasing recognition that our national policies are far from optimal in this new era of rapidly advancing personalized oncology.
- Home
- FKH
- FKH
- The Innovator’s Partner for over 25 Years
- Team
- FKH Cares
- History
- Philosophy
- Revolutionizing Healthcare
- Point….Click….Query….Discover!
- Power IT Up: Big Data Meets Healthcare
- Revolutionizing Healthcare Archive
- What Facebook’s Graph Search Means for Healthcare
- Funding the Next Discovery
- The FKH Commitment to Rare Disease
- Consumer Genetics Conference 2012 Recap
- Collaborating with Nonprofits on Medical Research
- Conference to Examine Actions and Policies Needed to Catalyze Progress in Personalized Cancer Medicine Despite Challenging Fiscal Environment
- Expanded Access Programs
- Biomedical “Spring”
- Milestone Events in Personalized Medicine
- TEDMED: Poetry Slam for Innovators
- FKH Leadership Evolution
- Pharma Collaboration with Patient Advocacy
- Connectivity Challenge
- PharmaVOICE 10th Anniversary: A Decade of Change
- The $1,000 Genome: From Laboratory to Lifestyle
- IT Leaders: Prepare for Personalized Medicine
- The “My-Health” Revolution: Communication Challenges in the Age of Personalized Medicine
- Families Fighting Flu Public Education Efforts
- Point….Click….Query….Discover!
- Ogilvy Relationship
- Locations
- FKH
- Expertise
- Practices
- Services
- Clients
- Impact
- Careers
- Contact
